James H. Holms

1.1k total citations
22 papers, 734 citations indexed

About

James H. Holms is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, James H. Holms has authored 22 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in James H. Holms's work include Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (5 papers) and Structural and Chemical Analysis of Organic and Inorganic Compounds (4 papers). James H. Holms is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (5 papers) and Structural and Chemical Analysis of Organic and Inorganic Compounds (4 papers). James H. Holms collaborates with scholars based in United States and United Kingdom. James H. Holms's co-authors include George W. Carter, James D. Ratajczyk, Francis A. J. Kerdesky, Richard D. Dyer, James B. Summers, Steven K. Davidsen, Daniel H. Albert, Hormoz Mazdiyasni, Patrick A. Marcotte and Patrick Young and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

James H. Holms

22 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James H. Holms United States 14 428 319 142 76 67 22 734
Charles G. Caldwell United States 20 510 1.2× 428 1.3× 160 1.1× 87 1.1× 115 1.7× 32 1.0k
Chun Sing Li Canada 14 321 0.8× 363 1.1× 80 0.6× 90 1.2× 57 0.9× 19 709
Kurt Eger Germany 18 532 1.2× 428 1.3× 84 0.6× 47 0.6× 69 1.0× 76 1.0k
Jagabandhu Das United States 18 588 1.4× 351 1.1× 164 1.2× 42 0.6× 64 1.0× 36 906
James E. Sheppeck United States 15 296 0.7× 313 1.0× 72 0.5× 53 0.7× 72 1.1× 24 628
Douglas G. Batt United States 18 405 0.9× 274 0.9× 92 0.6× 35 0.5× 105 1.6× 35 803
Baihua Hu United States 17 432 1.0× 225 0.7× 116 0.8× 39 0.5× 38 0.6× 25 665
Darin E. Jones United States 20 373 0.9× 297 0.9× 69 0.5× 73 1.0× 39 0.6× 44 796
Todd L. Graybill United States 16 351 0.8× 414 1.3× 125 0.9× 32 0.4× 75 1.1× 29 818
Michael P. Wachter United States 18 463 1.1× 261 0.8× 119 0.8× 26 0.3× 123 1.8× 45 796

Countries citing papers authored by James H. Holms

Since Specialization
Citations

This map shows the geographic impact of James H. Holms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Holms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Holms more than expected).

Fields of papers citing papers by James H. Holms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Holms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Holms. The network helps show where James H. Holms may publish in the future.

Co-authorship network of co-authors of James H. Holms

This figure shows the co-authorship network connecting the top 25 collaborators of James H. Holms. A scholar is included among the top collaborators of James H. Holms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. Holms. James H. Holms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Junling, Michael J. Staver, Michael L. Curtin, et al.. (2004). Expression and functional characterization of recombinant human HDAC1 and HDAC3. Life Sciences. 74(22). 2693–2705. 37 indexed citations
2.
Wada, Carol K., Robin R. Frey, Zhiqin Ji, et al.. (2003). α-Keto amides as inhibitors of histone deacetylase. Bioorganic & Medicinal Chemistry Letters. 13(19). 3331–3335. 67 indexed citations
3.
Holms, James H., Patrick A. Marcotte, Junling Li, et al.. (2001). Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-α converting enzyme. Bioorganic & Medicinal Chemistry Letters. 11(22). 2907–2910. 41 indexed citations
4.
Dellaria, Joseph F., James H. Holms, Jennifer J. Bouska, et al.. (2001). Biaryl Ether Retrohydroxamates as Potent, Long-lived, Orally Bioavailable MMP Inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(12). 1553–1556. 43 indexed citations
5.
Wada, Carol K., James H. Holms, Michael L. Curtin, et al.. (2001). Phenoxyphenyl SulfoneN-Formylhydroxylamines (Retrohydroxamates) as Potent, Selective, Orally Bioavailable Matrix Metalloproteinase Inhibitors. Journal of Medicinal Chemistry. 45(1). 219–232. 81 indexed citations
6.
Marcotte, Patrick A., Zhiwen Guan, Terrance J. Magoc, et al.. (1999). Evaluation of the Inhibition of other Metalloproteinases by Matrix Metalloproteinase Inhibitors. Journal of enzyme inhibition. 14(6). 425–435. 6 indexed citations
7.
Steinman, Douglas H., Michael L. Curtin, Robert B. Garland, et al.. (1998). The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(16). 2087–2092. 26 indexed citations
8.
Albert, Daniel H., Richard G. Conway, Terrance J. Magoc, et al.. (1996). Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 277(3). 1595–1606. 5 indexed citations
9.
Albert, Daniel H., Terrance J. Magoc, Paul Tapang, et al.. (1996). ABT-299, A NOVEL PAF ANTAGONIST, ATTENUATES MULTIPLE EFFECTS OF ENDOTOXEMIA IN CONSCIOUS RATS. Shock. 6(2). 112–117. 12 indexed citations
10.
Davidsen, Steven K., James B. Summers, David J. Sweeny, et al.. (1995). Synthesis of active metabolites of indole pyrrolothiazole paf antagonists. Bioorganic & Medicinal Chemistry Letters. 5(23). 2909–2912. 6 indexed citations
11.
Sheppard, George S., Steven K. Davidsen, George M. Carrera, et al.. (1995). Synthesis and evaluation of water soluble indole pyrrolothiazole paf antagonists. Bioorganic & Medicinal Chemistry Letters. 5(23). 2913–2918. 3 indexed citations
12.
Holms, James H., Steven K. Davidsen, George S. Sheppard, et al.. (1995). Discovery and optimization of indole pyrrolothiazole paf antagonists. Bioorganic & Medicinal Chemistry Letters. 5(23). 2903–2908. 2 indexed citations
13.
Summers, James B., Daniel H. Albert, James H. Holms, et al.. (1994). N-(Acyloxyalkyl)pyridinium Salts as Soluble Prodrugs of a Potent Platelet Activating Factor Antagonist. Journal of Medicinal Chemistry. 37(26). 4423–4429. 39 indexed citations
14.
Kerdesky, Francis A. J., et al.. (1991). 4-Hydroxythiazole inhibitors of 5-lipoxygenase. Journal of Medicinal Chemistry. 34(7). 2158–2165. 35 indexed citations
15.
Summers, James B., Ki H. Kim, Hormoz Mazdiyasni, et al.. (1990). Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. Journal of Medicinal Chemistry. 33(3). 992–998. 47 indexed citations
16.
Haviv, Fortuna, James D. Ratajczyk, Francis A. J. Kerdesky, et al.. (1988). 3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation. Journal of Medicinal Chemistry. 31(9). 1719–1728. 145 indexed citations
17.
Kerdesky, Francis A. J., Steven P. Schmidt, James H. Holms, et al.. (1987). Synthesis and 5-lipoxygenase inhibitory activity of 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid analogs. Journal of Medicinal Chemistry. 30(7). 1177–1186. 27 indexed citations
18.
Summers, James B., Hormoz Mazdiyasni, James H. Holms, et al.. (1987). Hydroxamic acid inhibitors of 5-lipoxygenase. Journal of Medicinal Chemistry. 30(3). 574–580. 73 indexed citations
19.
Tadanier, Jack, et al.. (1983). 3-Amino-3-demethoxyfortimicin A and the c-2 epimeric-2-amino-3-o-demethyl-2-deoxyfortimicins A.. The Journal of Antibiotics. 36(3). 267–275. 4 indexed citations
20.
Tadanier, Jack, Jerry R. Martin, Alex M. Nadzan, et al.. (1981). 2-Substituted fortimicins by ring opening of 2-deoxy-1,2-epimino-2-epi-fortimicin B and by nucleophilic displacements of 2-O-(methylsulfonyl)fortimicin derivatives. Carbohydrate Research. 96(2). 185–203. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles G. Caldwell Breakdown of academic impact, for papers by Chun Sing Li Breakdown of academic impact, for papers by Kurt Eger Breakdown of academic impact, for papers by Jagabandhu Das Breakdown of academic impact, for papers by James E. Sheppeck Breakdown of academic impact, for papers by Douglas G. Batt Breakdown of academic impact, for papers by Baihua Hu Breakdown of academic impact, for papers by Darin E. Jones Breakdown of academic impact, for papers by Todd L. Graybill Breakdown of academic impact, for papers by Michael P. Wachter
Rankless by CCL
2026